Home » Topics » BioWorld Science

BioWorld Science
RSS

ZEN-3694 reverses acquired resistance to CDK4/6 inhibitors in ER+ breast cancer

Sep. 7, 2021

Anti-VISTA antibody PMC-309 shows antitumor activity in vivo

Sep. 7, 2021

Curadev Pharma presents new STING antagonists

Sep. 7, 2021

Monoglyceride lipase inhibitors identified at Janssen

Sep. 7, 2021

Boehringer Ingelheim describes new plasma kallikrein inhibitors

Sep. 7, 2021

New DGAT-2 inhibitors discovered at Inorbit Therapeutics

Sep. 7, 2021

Neurons derived from iPSCs capture encoded genetic risk for Alzheimer's disease

Sep. 7, 2021

ADAMTS15 genetic variation causes hand and feet contractures without palmar creases

Sep. 7, 2021

4-PBA and TUDCA reduce symptoms in murine model of Alport syndrome

Sep. 7, 2021

IRF5 inhibition suppresses lupus-like disease in mice

Sep. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...